Engineering iron-based nanomaterials for breast cancer therapy associated with ferroptosis

Ruixue Wei,Gaoliang Fu,Zhe Li,Yang Liu,Mengzhou Xue

DOI: https://doi.org/10.2217/nnm-2023-0270

2024-02-01

Nanomedicine

Abstract:Ferroptosis has received increasing attention as a novel nonapoptotic programmed death. Recently, iron-based nanomaterials have been extensively exploited for efficient tumor ferroptosis therapy, as they directly release high concentrations of iron and increase intracellular reactive oxygen species levels. Breast cancer is one of the commonest malignant tumors in women; inhibiting breast cancer cell proliferation through activating the ferroptosis pathway could be a potential new target for patient treatment. Here, we briefly introduce the background of ferroptosis and systematically review the current cancer therapeutic strategies based on iron-based ferroptosis inducers. Finally, we summarize the advantages of these various ferroptosis inducers and shed light on future perspectives. This review aims to provide better guidance for the development of iron-based nanomaterial ferroptosis inducers. Part reprinted (adapted) with permission from [1] © American Chemical Society (2019); part reprinted (adapted) with permission from [2] © Elsevier (2018); part reprinted (adapted) with permission from [3] © American Chemical Society (2018).

biotechnology & applied microbiology,nanoscience & nanotechnology